financetom
Business
financetom
/
Business
/
Zoom Communications' AI-First Platform Strategy Showing Clear Progress, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Zoom Communications' AI-First Platform Strategy Showing Clear Progress, RBC Says
Nov 25, 2025 9:01 AM

11:43 AM EST, 11/25/2025 (MT Newswires) -- Zoom Communications' ( ZM ) platform shift toward AI-first collaboration and customer experience is showing measurable progress across products and clients, RBC said in a note Tuesday.

The company raised its Q4 and full-year forecasts after exceeding Q3 estimates, with growing AI adoption and steady enterprise demand, the investment firm said.

AI Companion 3.0 adoption grew more than fourfold year over year, while new enterprise wins included Oracle (ORCL) and Salesforce ( CRM ) , according to the note.

Customer experience annual recurring revenue climbed at a high double-digit rate, and Workvivo customers increased 70% to 1,225, RBC added.

The company approved a new $1 billion buyback after repurchasing $414 million in Q3, with RBC analysts seeing further shareholder return potential even amid low-single-digit revenue growth.

Shares of the company were up about 13% in recent trading.

RBC maintained an outperform rating for Zoom with a $100 price target.

Price: 88.66, Change: +10.06, Percent Change: +12.80

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gilead Sciences, US government settle patent case over HIV prevention drugs
Gilead Sciences, US government settle patent case over HIV prevention drugs
Jan 15, 2025
(Reuters) - Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court. The settlement follows a victory for Gilead in a 2023 jury trial on the government's patent infringement allegations. Gilead General Counsel Deborah Telman said in a statement that the...
Automotive Properties REIT Declares January 2025 Distribution
Automotive Properties REIT Declares January 2025 Distribution
Jan 15, 2025
03:49 PM EST, 01/15/2025 (MT Newswires) -- Automotive Properties REIT (APR-UN.TO) Wednesday declared a distribution of $0.067 per REIT unit for the month of January, representing $0.804 per REIT unit on an annualized basis. This is consistent with December's cash distribution. Payment will be made on Feb. 18 to unitholders of record on Jan. 31. Price: 10.66, Change: +0.08, Percent...
Senators demand US trade chief Tai halt late talks on investor protections
Senators demand US trade chief Tai halt late talks on investor protections
Jan 15, 2025
WASHINGTON (Reuters) - A bipartisan group of U.S. senators on Wednesday called on U.S. Trade Representative Katherine Tai to stop secret negotiations with Mexico, Canada and Colombia that would weaken investor protections in some U.S. free trade deals during the Biden administration's final days. The letter, led by Senate Finance Committee Chairman Mike Crapo, a Republican, and the panel's top...
Gilead Sciences, US government settle patent case over HIV prevention drugs
Gilead Sciences, US government settle patent case over HIV prevention drugs
Jan 15, 2025
Jan 15 (Reuters) - Gilead Sciences ( GILD ) and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court. The settlement follows a victory for Gilead in a 2023 jury trial on the government's patent infringement allegations. Gilead General Counsel Deborah Telman said...
Copyright 2023-2025 - www.financetom.com All Rights Reserved